SWTXSpringWorks Therapeutics, Inc.

Nasdaq springworkstx.com


$ 43.32 $ -0.62 (-1.41 %)    

Wednesday, 24-Apr-2024 15:59:56 EDT
QQQ $ 422.96 $ 1.44 (0.34 %)
DIA $ 384.57 $ -0.58 (-0.15 %)
SPY $ 502.89 $ -0.24 (-0.05 %)
TLT $ 88.37 $ -0.63 (-0.71 %)
GLD $ 214.61 $ -0.40 (-0.19 %)
$ 43.38
$ 44.49
$ 40.31 x 100
$ 46.30 x 100
$ 43.07 - $ 44.58
$ 18.00 - $ 53.92
504,700
na
2.74B
$ 0.71
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-27-2024 12-31-2023 10-K
2 11-02-2023 09-30-2023 10-Q
3 08-02-2023 06-30-2023 10-Q
4 05-03-2023 03-31-2023 10-Q
5 02-28-2023 12-31-2022 10-K
6 11-03-2022 09-30-2022 10-Q
7 08-04-2022 06-30-2022 10-Q
8 05-05-2022 03-31-2022 10-Q
9 02-24-2022 12-31-2021 10-K
10 11-04-2021 09-30-2021 10-Q
11 08-04-2021 06-30-2021 10-Q
12 05-05-2021 03-31-2021 10-Q
13 02-25-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-12-2020 06-30-2020 10-Q
16 05-12-2020 03-31-2020 10-Q
17 03-12-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-springworks-therapeutics-raises-price-target-to-74

HC Wainwright & Co. analyst Robert Burns maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Buy and raises the pric...

 jp-morgan-maintains-overweight-on-springworks-therapeutics-raises-price-target-to-74

JP Morgan analyst Anupam Rama maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Overweight and raises the price target...

 barclays-maintains-overweight-on-springworks-therapeutics-raises-price-target-to-63

Barclays analyst Peter Lawson maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Overweight and raises the price target...

 wedbush-maintains-outperform-on-springworks-therapeutics-raises-price-target-to-70

Wedbush analyst David Nierengarten maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Outperform and raises the price t...

 barclays-maintains-overweight-on-springworks-therapeutics-raises-price-target-to-47

Barclays analyst Peter Lawson maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Overweight and raises the price target...

 why-springworks-therapeutics-stock-swtx-is-nosediving

SpringWorks Therapeutics Inc (NASDAQ: SWTX) shares are trading lower by 8.4% to $29.00 Tuesday morning after the company announ...

 springworks-therapeutics-prices-upsized-public-offering-of-9482758-common-shares-at-29share

The gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, ...

 springworks-therapeutics-commences-public-offering-of-250m-of-shares-of-its-common-stock

In addition, SpringWorks expects to grant the underwriters a 30-day option to purchase up to an additional $37.5 million of sha...

 why-titan-machinery-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results.

 la-z-boy-posts-upbeat-earnings-joins-victorias-secret-snowflake-and-other-big-stocks-moving-higher-on-thursday

U.S. stocks traded mostly higher, with the Dow Jones index gaining around 200 points on Thursday.

 goldman-sachs-maintains-buy-on-springworks-therapeutics-raises-price-target-to-52

Goldman Sachs analyst Corinne Jenkins maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Buy and raises the price targe...

 hc-wainwright--co-maintains-buy-on-springworks-therapeutics-raises-price-target-to-73

HC Wainwright & Co. analyst Robert Burns maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Buy and raises the pric...

 why-senestech-shares-are-trading-lower-by-around-50-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of SenesTech, Inc. (NASDAQ: SNES) shares moved lower during Tuesday’s session after the company reported pricing of $5....

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION